Weight Outcomes After 1 year of follow-up with continuous treatment, the mean (SD) weight was 89.9 (22.4) kg in the semaglutide 2.4 mg cohort and 87.6 (22.6) kg in the tirzepatide cohort (Table 3)
If you experience severe vomiting or diarrhea, temporarily hold your next dose and contact your healthcare provider, as dehydration can increase the risk of acute kidney injury
For patients without a gallbladder, the experience of these side effects may differ in character or intensity due to altered bile flow and fat digestion patterns
For instance, active infections, recent surgical procedures, certain chronic diseases, and specific medication use can affect eligibility
He has maintained a 4.7+ Google rating throughout his career in practice, and patients travel from abroad and from all over the United States for his expertise in peripheral nerve diagnosis and treatment
Its headline job is to ferry long-chain fatty acids into mitochondria so they can be oxidized for energy